3D Global Biotech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	30.34	17.45	56.12	21.82	15.53	20.37
Short-Term Investments	453.78	459.8	647.74	144.2	192.9	212.8
Cash & Short-Term Investments	497.11	477.25	703.86	166.02	208.43	233.17
Cash Growth	-35.47%	-32.20%	323.97%	-20.35%	-10.61%	-15.74%
Accounts Receivable	16.92	71.98	119.58	1.35	1.09	1.23
Other Receivables	-	1	2.99	0.59	0.44	0.41
Receivables	16.92	72.98	122.57	1.94	1.53	1.64
Inventory	18.67	22.38	7.04	3.6	3.37	0.88
Other Current Assets	0.14	1.9	2.34	4.12	2.68	4.15
Total Current Assets	551.05	574.51	835.81	175.67	216.01	239.85
Property, Plant & Equipment	74.5	59.82	92.77	13.15	21.02	28.17
Long-Term Investments	66.51	355.6	-	-	-	-
Other Intangible Assets	66.1	73.17	87.79	102.29	117.09	152.3
Long-Term Deferred Tax Assets	58.97	26.21	18.56	16.27	15.31	3.2
Other Long-Term Assets	1.34	1.34	2.65	16.77	1.84	0.99
Total Assets	818.48	1,091	1,038	324.15	371.26	424.52
Accounts Payable	0.74	2.77	16.08	3.33	2.22	0.67
Accrued Expenses	-	13.02	14.34	7.69	7.61	6.35
Current Portion of Leases	7.09	7.02	11	6.3	6.37	5.5
Current Unearned Revenue	5.13	14.4	6.63	7.31	2.22	-
Other Current Liabilities	32.26	3.59	4.41	1.87	1.74	2.44
Total Current Liabilities	47.48	40.8	52.46	26.49	20.17	14.95
Long-Term Leases	38.07	41.63	73.77	4.08	10.38	15.81
Long-Term Deferred Tax Liabilities	0.2	23.69	6.65	-	-	3.94
Other Long-Term Liabilities	-	-	-	0.11	0.11	0.11
Total Liabilities	85.75	106.12	132.88	30.68	30.66	34.81
Common Stock	778.4	778.4	778.4	568.09	557.4	539.7
Additional Paid-In Capital	-	37.76	34.59	1.22	2.08	1.8
Retained Earnings	94.93	116.96	91.7	-275.84	-218.88	-151.79
Treasury Stock	-43.02	-43.02	-	-	-	-
Comprehensive Income & Other	-97.59	94.43	-	-	-	-
Shareholders' Equity	732.73	984.53	904.69	293.47	340.6	389.71
Total Liabilities & Equity	818.48	1,091	1,038	324.15	371.26	424.52
Total Debt	45.16	48.66	84.76	10.38	16.75	21.31
Net Cash (Debt)	451.95	428.59	619.1	155.64	191.68	211.87
Net Cash Growth	-33.91%	-30.77%	297.78%	-18.80%	-9.53%	-17.22%
Net Cash Per Share	5.71	5.41	8.75	2.77	3.49	3.93
Filing Date Shares Outstanding	79.13	76.98	77.84	56.81	55.74	53.97
Total Common Shares Outstanding	79.13	76.98	77.84	56.81	55.74	53.97
Working Capital	503.57	533.71	783.35	149.17	195.84	224.9
Book Value Per Share	9.26	12.79	11.62	5.17	6.11	7.22
Tangible Book Value	666.63	911.36	816.91	191.18	223.52	237.41
Tangible Book Value Per Share	8.42	11.84	10.49	3.37	4.01	4.40
Machinery	-	25.29	20.25	14.61	14.38	13.77
Leasehold Improvements	-	13.25	13.15	12.57	12.57	12.57